Quantinuum sets its IPO price at $1.68 billion, establishing a new benchmark for the quantum industry.

      The price range for the offering was set between $53 and $55, but Quantinuum was priced at $60. This willingness of investors to pay more than what bankers requested is the key highlight of the Honeywell-backed company's initial public offering, which raised $1.68 billion and established a benchmark valuation for the entire quantum computing industry.

      The process is quite simple. Quantinuum sold 28 million shares, increased from a planned 26.5 million, at $60 each, as reported by a source cited by Reuters. This pricing gives the company an estimated valuation of around $15.6 billion based on the share count in its filings. It will commence trading on the Nasdaq on Thursday under the ticker QNT, with JPMorgan and Morgan Stanley leading the offering.

      The final amount represents a consistent rise in ambition. Initial targets aimed for around an increased $1.46 billion at a valuation of approximately $14.3 billion, which itself was an increase from the $12.7 billion the company was said to have settled on after the $20 billion-plus filing began circulating. The $1.68 billion priced at $60 surpasses those previous figures; the perception of the IPO has evolved as the book solidified, and the latest number is what truly matters.

      What investors are acquiring is more about future potential than current earnings. Quantinuum projected approximately $31 million in revenue for 2025, with a valuation now exceeding $15 billion, creating a ratio that positions the listing as a gamble on what the company might achieve rather than what it currently generates in sales.

      Established in 2021 through the merger of Honeywell’s quantum division and Cambridge Quantum, the company develops quantum computers designed to tackle problems that would take classical machines an impractically long time to solve. It is aiming to create a fault-tolerant machine it has named Apollo, targeted for release in 2029.

      Honeywell continues to play a pivotal role in the company following the offering, expected to maintain about 49% of the voting rights afterward, with founding stakeholders Honeywell and Cambridge Quantum Holdings together retaining around 82% of the equity.

      In numerical terms, the IPO serves not only as a partial monetization of an industrial conglomerate's scientific investment but also as an introduction for the quantum firm itself. This structure provides Quantinuum with new public capital and allows Honeywell to realize a market value on an asset it has owned since the merger.

      The implications extend beyond Quantinuum’s financials. This is the largest quantum computing IPO to date, making its pricing a benchmark for a sector that has been rich in scientific achievements yet lacking in public market comparability.

      Competitors already publicly traded and those considering their own IPOs now have a figure to measure against, demonstrating that public investors are willing to pay above the stated range for exposure to quantum technology.

      Whether this enthusiasm will endure through quarterly reports remains an unanswered question, and the pricing does not clarify this. A debut above the expected range indicates demand on a singular occasion.

      Apollo is several years away, current revenue is modest, and the gap between a $15.6 billion valuation and a fully operational fault-tolerant computer reflects the challenge the sector has faced for the past decade. For now, Quantinuum has set a new standard. Trading begins on Thursday.